- A CPCT/A collects a blood specimen for a stat glucose test at 0630 hours. The patient's wristband shows: "Martinez, Rosa DOB: 02/14/1978 MRN: 789456." However, the pre-printed label from the requisition shows: "Martinez, Rose DOB: 02/14/1978 MRN: 789456." All other information matches exactly. What is the most appropriate action regarding specimen labeling?
Answer: Do not label the specimen and contact the laboratory or nursing staff immediately to resolve the patient identification discrepancy
Any discrepancy in patient identifiers, even seemingly minor name variations, requires immediate resolution before labeling specimens. The specimen should not be labeled until the identification discrepancy is resolved by appropriate personnel. Manually altering labels is not permitted, and patient preference does not determine official identification. Even though other identifiers match, the name discrepancy could indicate a registration error or mix-up that must be resolved.
- While collecting specimens for a glucose tolerance test, a CPCT/A draws the fasting specimen at 0800 and labels it correctly. At 1000, after the patient drinks the glucose solution, the second specimen is collected. When applying the label to the 1000 specimen, the CPCT/A realizes the pre-printed label shows an incorrect collection time of 0900. The specimen was definitely collected at 1000. What is the most appropriate action?
Answer: Do not use the incorrect label; contact the laboratory or nursing supervisor to obtain a corrected label showing 1000 as the collection time
For glucose tolerance tests, accurate collection times are critical for proper interpretation of results. Labels with incorrect collection times cannot be altered or used with attached notes, as this violates specimen integrity protocols. A new label with the correct collection time must be obtained. The 1-hour timing difference would significantly affect the interpretation of glucose tolerance test results, making accurate labeling essential.
- During a busy morning shift, a CPCT/A is collecting specimens from multiple patients in the same room. After drawing blood from Patient A (John Smith, DOB 3/15/1965) for a lipid panel, the CPCT/A moves to Patient B (James Smith, DOB 3/15/1967) for a basic metabolic panel. Both patients confirm their identities verbally. When labeling the specimens at the bedside, which approach best ensures proper specimen identification?
Answer: Compare the patient wristband information to the specimen label for each patient immediately after drawing their blood and before moving to the next patient
Proper specimen labeling requires immediate labeling at the bedside using two patient identifiers from the patient's wristband, not verbal confirmation. This must be done immediately after collection and before leaving each patient's side. With similar names and birth dates, relying on verbal confirmation or room location creates high risk for specimen mix-ups. Pre-printed labels must still be verified against wristband information at the bedside.
- A CPCT/A is collecting blood specimens from a patient scheduled for surgery. The patient's wristband shows "Johnson, Michael" but when asked to state his name, the patient says "My name is Mike Johnson, but everyone calls me Mikey." The pre-printed specimen label shows "Johnson, Michael." The patient's date of birth and medical record number on the wristband match the label exactly. How should the CPCT/A proceed with specimen labeling?
Answer: Apply the pre-printed label since "Mike" is a common nickname for "Michael" and the other identifiers match perfectly
When a patient provides a common nickname (Mike for Michael) but the formal name on the wristband matches the specimen label, and other identifiers (DOB, MRN) match exactly, this is acceptable for specimen labeling. "Mike" is a universally recognized nickname for "Michael." The specimens can be labeled using the pre-printed labels. Labels should never be manually altered, and this minor name variation does not require nursing intervention.
- A CPCT/A is preparing to label blood specimens collected from an unconscious patient in the ICU. The patient has no wristband because it was removed during an emergency procedure. A nurse provides the patient information verbally and shows the CPCT/A the patient's chart. The specimens were collected for multiple stat tests including cardiac enzymes. How should the CPCT/A proceed with specimen labeling?
Answer: Do not label the specimens until a new patient wristband is placed on the patient and two identifiers can be verified from the band
Patient identification is one of the most critical safety protocols in healthcare, and this question tests your understanding of proper specimen labeling procedures when standard identification methods aren't available.
The correct approach is A - you must wait for a new wristband to be placed so you can verify two patient identifiers directly from the band. Patient identification requires two independent, reliable identifiers (typically name and date of birth or medical record number) that you can verify from an approved source attached to the patient. The wristband serves as the primary identification source because it's physically connected to the patient, eliminating any possibility of mix-ups.
Option B is incorrect because using a nurse as a "second identifier source" violates identification protocols - you need two pieces of patient information, not two people confirming information. Option C is wrong because the chart isn't attached to the patient, creating risk of mislabeling if you're looking at the wrong chart or if charts were mixed up. Option D fails because room numbers are never acceptable patient identifiers - patients can be moved between rooms, and you could easily be in the wrong room.
The emergency nature of the tests (stat cardiac enzymes) might make you feel pressured to rush, but patient safety always takes priority over speed. A few extra minutes to properly identify the patient prevents potentially catastrophic consequences from mislabeled specimens.
Remember: When you see identification questions on the CPCTA exam, look for answers that require direct verification from the patient or their wristband - never accept shortcuts involving charts, room numbers, or verbal confirmation alone.
- A CPCT/A draws blood from a patient at 1430 hours for a glucose test and a CBC. The glucose tube is collected first, followed by the CBC tube. Both tubes are properly filled and mixed. However, when labeling the specimens, the CPCT/A accidentally places the glucose label on the CBC tube and the CBC label on the glucose tube before leaving the patient's room. What is the most appropriate action to take?
Answer: Discard both specimens, obtain new collection tubes, and redraw the patient after properly preparing new labels
When specimen labeling errors occur, the specimens must be discarded and redrawn to ensure patient safety and accurate test results. Relabeling specimens after they have left the patient's bedside violates specimen integrity protocols and could lead to dangerous misidentification. Laboratory personnel cannot and should not switch labels, as this creates a chain of custody violation. The only safe option is to discard the mislabeled specimens and redraw the patient with properly labeled tubes.
- A CPCT/A successfully collects blood specimens from a pediatric patient for a CBC and basic metabolic panel. The child's wristband information is verified before collection. When labeling the specimens at the bedside, the CPCT/A notices that both pre-printed labels have identical patient information but neither label specifies which test is for which tube. The purple-top tube contains the CBC specimen and the green-top tube contains the basic metabolic panel specimen. How should the CPCT/A properly label these specimens?
Answer: Apply the labels to the tubes as provided, since the laboratory will identify the correct tests based on the tube additives and colors
When you encounter specimen labeling questions, focus on standard laboratory protocols and proper identification procedures. The key principle is that specimens must be accurately identified while following established healthcare facility procedures.
The correct approach is option D - apply the labels as provided since laboratories routinely identify tests based on tube additives and colors. This is standard practice because different colored tube tops contain specific additives designed for particular tests. Purple-top tubes contain EDTA for hematology tests like CBC, while green-top tubes contain heparin for chemistry panels like BMP. Laboratory personnel are trained to recognize these standardized tube types and process them accordingly. The patient identification on the labels is the critical safety element, not the test specification.
Option A is incorrect because writing additional information on pre-printed labels can violate facility protocols and potentially compromise the label's integrity or readability. Option B creates confusion by applying duplicate labels to both specimens, which could lead to processing errors and violates standard one-label-per-specimen protocols. Option C unnecessarily delays specimen processing when the current labeling system is adequate - laboratories don't require test names on labels when standardized collection tubes are used correctly.
Remember for the CPCTA exam: specimen labeling questions often test whether you understand that patient identification is the primary labeling concern, while test identification relies on standardized collection systems. Don't overthink scenarios where standard protocols are already in place - trust the established laboratory systems rather than creating workarounds that might introduce errors.
- A CPCT/A is collecting specimens for chain of custody drug testing on a patient involved in a motor vehicle accident. After successful venipuncture, the specimen tubes are filled appropriately. When applying the specimen labels at the bedside, the CPCT/A must ensure proper chain of custody documentation. In addition to standard patient identification labels, what is specifically required for these specimens?
Answer: Tamper-evident seals on the specimen containers and completion of chain of custody forms with witness signatures before leaving the patient's bedside
Chain of custody specimens require tamper-evident seals and proper chain of custody documentation completed at the bedside with appropriate witness signatures to maintain legal integrity. Standard patient identification labels alone are insufficient for forensic specimens. The chain of custody process must be initiated immediately upon collection. While collector identification and timing are important, tamper-evident seals and witness documentation are the specific additional requirements for legal specimens.
- A CPCT/A collects a blood specimen for blood cultures from a patient with suspected sepsis. The collection is performed using proper sterile technique at 1415 hours. When labeling the aerobic and anaerobic culture bottles at the bedside, the CPCT/A notices that the pre-printed labels do not indicate which bottle is aerobic and which is anaerobic. Both bottles have identical patient information labels applied. What additional labeling is required?
Answer: No additional labeling is needed since the laboratory can identify bottle types by their color coding and manufacturer specifications
Blood culture bottles are manufactured with distinct color coding and labeling that allows laboratory personnel to identify aerobic and anaerobic bottles without additional marking by the collector. The patient identification labels are sufficient for specimen tracking. Writing on bottle caps or adding extra labels is not required and may interfere with laboratory processing. Documentation in the chart is not necessary for bottle identification.
- During a blood draw for multiple tests, a CPCT/A collects specimens in the following order: light blue tube (PT/PTT), red tube (chemistry panel), and purple tube (CBC). After collection, while labeling the specimens at the patient's bedside, one of the labels falls onto the floor of the patient room. The CPCT/A picks up the label, and it appears clean with no visible contamination. What is the most appropriate action for labeling these specimens?
Answer: Discard the floor label and obtain a replacement label before completing the labeling of all three specimens
This question tests your understanding of specimen integrity and infection control protocols in laboratory specimen collection. When any collection material becomes potentially contaminated, you must prioritize patient safety and specimen accuracy over convenience.
The correct action is D - discard the floor label and obtain a replacement. Even though the label appears clean, hospital floors are considered contaminated surfaces regardless of visible dirt. Using any potentially contaminated material in specimen collection violates fundamental infection control principles and could compromise the integrity of laboratory results. Patient identification labels must remain sterile throughout the collection process to ensure accurate testing and prevent any risk of introducing pathogens into the laboratory environment.
Option A is wrong because no laboratory test is "less sensitive" to contamination - all specimens require the same sterile handling standards, and prioritizing one test type over another based on perceived contamination tolerance is inappropriate. Option B fails because alcohol wipes cannot guarantee complete decontamination of a label that has contacted a hospital floor, and this practice violates standard protocols. Option C is incorrect because placing a contaminated label in a bag with the specimen doesn't eliminate the contamination risk - it actually introduces a known contaminant into the transport container.
Remember this key principle for the CPCT/A exam: when in doubt about contamination, always err on the side of caution and replace the potentially compromised material. Questions about specimen collection often test whether you'll choose convenience over proper protocol - always choose protocol compliance and patient safety.
